Metraipolis › archive › dc_a76854daaec2

Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with… — Europe PMC PMID:40871097

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40871097
DOI
10.3390/pharmaceutics17081078
License (as archived)
solo-consultazione
Archived
2026-11-10T11:48:17.035Z
SHA-256 of the archived text
c92edd99529fe67377d92529a7d1f82579a2e9897faeae3d055e2a87c4f373d7
Stable URL of this page
https://metraipolis.com/documento/dc_a76854daaec2

How to cite

Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with… — Europe PMC PMID:40871097 — Europe PMC (en), https://europepmc.org/article/MED/40871097 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a76854daaec2 (Metraipolis archive dc_a76854daaec2, sha256 c92edd99529fe67377d92529a7d1f82579a2e9897faeae3d055e2a87c4f373d7)
BibTeX
@misc{dca76854daaec2,
  title = {Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with… — Europe PMC PMID:40871097},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40871097},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a76854daaec2; sha256 c92edd99529fe67377d92529a7d1f82579a2e9897faeae3d055e2a87c4f373d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40871097. Agents can read the archived copy with the MCP tool read_document.